The HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission has released updates to its Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. New information on HIV in pregnant women, preconception counseling and care of HIV-positive women, and other important updates are explained in the What’s New In the Guidelines highlights.

The CCC maintains current Guidelines and key guidances on its HIV/AIDS Guidelines page. For assistance with clinical questions about how changes to the Perinatal Guidelines affect your practice, or for other questions on prevention and care in HIV-positive pregnant women and their infants, contact the Perinatal HIV Hotline for expert advice from a clinical consultant at (888) 448-8765, 24 hours a day, seven days a week.